An interventional study of High frequency chest wall oscillation or other airway clearance therapy and Oscillation and lung expansion in Atelectasis, sponsored by Capital Medical University. Recruiting at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-05.
Sponsored by Capital Medical University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Pulmonary Atelectasis with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Pulmonary Atelectasis · China.
Among the 24 studies in Pulmonary Atelectasis with a site in China, this one is the 14th largest by planned enrollment of the 21 interventional ones that give a count, is one of 5 that started in 2026, is one of 19 with no phase, reaches primary completion later than 6 of the 13 other live ones, and was the 21st registered.
378 studies on the registry are indexed under Pulmonary Atelectasis; 91 are open to participants now.
Browse Pulmonary Atelectasis studies →13 of the 24 studies in Pulmonary Atelectasis with a site in China are open now. Recruiting first, the newest first:
Southeast University, China · Sites in China
Ages 18+
The First Affiliated Hospital of Xinxiang Medical College · Sites in China
Ages 18+ · Women only
Tongji Hospital · Sites in China
Ages 18–80
Shanghai Zhongshan Hospital · Sites in China
Ages 20–90
Shanghai Zhongshan Hospital · Sites in China
Ages 18 mo–80 yrs
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 51 Pulmonary Atelectasis studies recruiting now, 20 (39%) set no upper age limit and 23 (45%) stop at 75 or younger; 24 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 5 started in 2026.
This study's planned enrollment of 60 is close to the median of 60 across 268 interventional studies indexed under Pulmonary Atelectasis.
Median enrollment 90 across the 21 interventional studies, 80 across the 3 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 24 has an industry lead sponsor. The 10 most frequent:
Capital Medical University is the lead sponsor of 296 studies on the registry; 90 are open to participants now.
Capital Medical University has 1 study filed under Pulmonary Atelectasis — fewer than ten, so there is no comparison to draw.
1 of the studies in Pulmonary Atelectasis with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07239557Sixth Affiliated Hospital, Sun Yat-sen UniversityOptimal Interval for Periodic Alveolar Recruitment Maneuvers Achieving 90% Lung Re-expansion During Intraoperative Ventilation | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 24 studies in Pulmonary Atelectasis with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
High frequency chest wall oscillation (HFCWO) is currently one of the most common and widespread mechanical airway clearance techniques (ACTs) in clinical practice in China. As an external airway oscillation technique, it has been proven in previous clinical practices that it can help clear secretions by vibrating the chest wall, loosening the secretions adhering to the airway walls and promoting ciliary movement, thereby improving lung ventilation and re-expansion. However, there are still some groups of patients for whom this technique is not suitable in clinical practice, such as those who are uncomfortable with the oscillation, have damaged skin on the chest and back, have unstable rib fractures, or have poorly positioned tracheostomy tubes. In recent years, integrating multiple techniques into a single treatment has become a trend. Among them, oscillation and lung expansion (OLE) combines continuous positive airway pressure (CPAP), continuous high-frequency oscillation (CHFO), and nebulization, which can effectively clear airway secretions and promote lung re-expansion. Currently, only a few studies have confirmed that OLE has a positive impact on improving respiratory function in patients with acute respiratory failure, severe burns, and after lung surgery.
This study aims to further compare the effects of the above two mechanical ACTs on improving lung ventilation and re-expansion by electrical impedance tomography (EIT), and optimize the clinical practice of physical therapists.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This group conducted casual treatment and airway clearance (except oscillation an lung expansion therapy)
Other: High frequency chest wall oscillation or other airway clearance therapy
This group conducted casual treatment and oscillation an lung expansion on daily therapy
Other: High frequency chest wall oscillation or other airway clearance therapy · Other: Oscillation and lung expansion
High frequency chest wall oscillation (HFCWO) is an external airway oscillation technique, it has been proven in previous clinical practices that it can help clear secretions by vibrating the chest wall, loosening the secretions adhering to the airway walls and promoting ciliary movement, thereby improving lung ventilation and re-expansion. We will give the patients HFCWO twice a day and each time we will give them 15HZ as frequency and 20mins as time. Other therapies are postural drainage, manual vibration...
oscillation and lung expansion (OLE) combines continuous positive airway pressure (CPAP), continuous high-frequency oscillation (CHFO), and nebulization, which can effectively clear airway secretions and promote lung re-expansion. The OLE will be given to the patients twice a day as well, and each time 10mins therapy with 2.5mins CPAP and 2.5mins CHFO cirsularly.
Change in Atelectatic Lung Area on Chest CT
Atelectatic lung area will be quantified on chest computed tomography (CT) images by a blinded radiologist using imaging analysis software. The primary outcome is the change in atelectatic lung area from baseline to 10 days post-treatment. The unit of the measures is Square centimeters (cm²)
Time frame: Baseline and 10 days post-treatment
Ventilation distribution on Electrical impedance tomography (EIT) evaluation
electrical impedance tomography will be used to evaluated the ventilation : Select a large, medium, or small electrode belt according to the patient's body size and place it on the chest (at the level of the 4th-5th intercostal spaces). Ensure that the belt position remains consistent for each measurement. Inject current through the electrode belt and measure the corresponding voltage to reconstruct the intrathoracic impedance distribution and display the corresponding images. Continuously record for 90 seconds and store the EIT data. Global inhomogeneity(GI) value describe the ventilation dstribute, the value is more closer to 0.25, is better.
Time frame: at admission and 3days/7days/10 days after treatment
Lung Ultrasound score(LUS)
Lung aeration will be assessed using the Lung Ultrasound Score (LUS).Scan 12 areas to get a relevent score for degrees of lung aeration of each area according the patterns that we got on the lung ultrasound. Each lung region will be scored according to standard criteria, and the total score will be calculated. The outcome measure is the change in total LUS from baseline to 10 days post-treatment. Score ranged from 0 to 36.Higher scores indicate worse lung aeration.
Time frame: at admission and 10 days after treatment
Oxygenation index
Oxygenation index is measured by fingertip blood oxygen and is expressed as a percentage.
Time frame: at admission and 10 days after treatment
the score on Modified Borg dyspnea scale
a number that reflect the degree of dyspnea on patient reporting according to the Modified Borg dyspnea scale
Time frame: at admission and 10 days after treatment
The Clinical Pulmonary Infection Score
The Clinical Pulmonary Infection Score (CPIS) is a pulmonary infection assessment system formed by integrating multiple clinical indicators such as body temperature, white blood cell count, and oxygenation index,scaled from 0 to 12, the higher scores, the higher risk of infection.
Time frame: from enrollment to 2 weeks after the treatment
daily cost
Daily cost in HDU was calculated by a speciallist nurse and is expressd as Chinese yuan
Time frame: in 10 days after admission
Not enrolling at this site.
Plan to share: Yes
No publications or documents are linked to this record.
Start is estimated for Mar 2026; primary completion for Apr 2026, 0 months later.
Of 155 non-industry interventional studies with no phase under Pulmonary Atelectasis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 0 months is below that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 5 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.